NCT06089707View on ClinicalTrials.gov

Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl

PHASE3RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Opioid Use Disorder
Interventions
DRUG

Naloxone Nasal Spray

IN naloxone will be administered to participants, after which a single dose of buprenorphine will be given to participants

Trial Locations (1)

21224

RECRUITING

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
collaborator

Cure Addiction Now

UNKNOWN

lead

Johns Hopkins University

OTHER